Cue Biopharma, Inc. (CUE) › Shareholders' EquityCue Biopharma, Inc. (CUE) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: $15.17M2017: $61.61M2018: $33.97M2019: $54.58M2020: $78.91M2021: $65.49M2022: $65.68M2023: $37.09M2024: $17.50M2025: $26.43M$26.43M2016Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$26.43M+51.0%2024$17.50M-52.8%2023$37.09M-43.5%2022$65.68M+0.3%2021$65.49M-17.0%2020$78.91M+44.6%2019$54.58M+60.7%2018$33.97M-44.9%2017$61.61M+306.0%2016$15.17M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share